FDx Advisors’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-5,518
| Closed | -$548K | – | 669 |
|
|
2019
Q3 | $548K | Buy |
5,518
+1,143
| +26% | +$109K | 0.04% | 328 |
|
|
2019
Q2 | $404K | Buy |
4,375
+54
| +1% | +$5.13K | 0.02% | 536 |
|
|
2019
Q1 | $408K | Sell |
4,321
-5,070
| -54% | -$443K | 0.02% | 500 |
|
|
2018
Q4 | $602K | Buy |
9,391
+2,363
| +34% | +$174K | 0.05% | 267 |
|
|
2018
Q3 | $629K | Sell |
7,028
-546
| -7% | -$48.3K | 0.02% | 464 |
|
|
2018
Q2 | $602K | Sell |
7,574
-99
| -1% | -$8.22K | 0.02% | 493 |
|
|
2018
Q1 | $685K | Sell |
7,673
-16,026
| -68% | -$1.54M | 0.02% | 629 |
|
|
2017
Q4 | $2.47M | Sell |
23,699
-3,379
| -12% | -$381K | 0.07% | 253 |
|
|
2017
Q3 | $3.95M | Buy |
27,078
+1,617
| +6% | +$220K | 0.11% | 152 |
|
|
2017
Q2 | $3.31M | Sell |
25,461
-6,067
| -19% | -$743K | 0.1% | 170 |
|
|
2017
Q1 | $3.92M | Buy |
31,528
+1,529
| +5% | +$183K | 0.12% | 158 |
|
|
2016
Q4 | $3.47M | Buy |
29,999
+14,750
| +97% | +$1.64M | 0.1% | 192 |
|
|
2016
Q3 | $1.59M | Sell |
15,249
-5,743
| -27% | -$622K | 0.07% | 261 |
|
|
2016
Q2 | $2.07M | Buy |
20,992
+8,646
| +70% | +$894K | 0.09% | 195 |
|
|
2016
Q1 | $1.24M | Buy |
12,346
+725
| +6% | +$74.7K | 0.06% | 303 |
|
|
2015
Q4 | $1.39M | Buy |
11,621
+2,556
| +28% | +$296K | 0.06% | 270 |
|
|
2015
Q3 | $981K | Sell |
9,065
-951
| -9% | -$118K | 0.08% | 254 |
|
|
2015
Q2 | $1.16M | Sell |
10,016
-6,484
| -39% | -$741K | 0.06% | 294 |
|
|
2015
Q1 | $1.9M | Buy |
16,500
+2,035
| +14% | +$243K | 0.04% | 350 |
|
|
2014
Q4 | $1.62M | Buy |
14,465
+7,011
| +94% | +$739K | 0.1% | 195 |
|
|
2014
Q3 | $706K | Buy |
7,454
+4,208
| +130% | +$380K | 0.05% | 450 |
|
|
2014
Q2 | $279K | Buy |
+3,246
| New | +$247K | 0.02% | 811 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
FDx Advisors's CELG Position: Q4 2019 in Review
FDx Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 5,518 shares — an estimated $548K sold.
FDx Advisors first reported a position in CELG in Q2 2014 and held it in 22 quarters. The position peaked at $3.95M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- FDx Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- FDx Advisors sold 5,518 Celgene Corp shares in Q4 2019, an estimated $548K.
- FDx Advisors first reported a position in Celgene Corp in Q2 2014 and held it in 22 quarters.
- FDx Advisors's Celgene Corp position peaked at $3.95M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on FDx Advisors's 13F filing for Q4 2019, filed 12 Feb 2020.